Hagop M. Kantarjian

6 ta ish

The University of Texas MD Anderson Cancer Center

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

   Michele Baccarani, Michael Deininger, Gianantonio Rosti +29

   Sharh maqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.108143

2. The effects of imatinib on pregnancy outcome

   Seonaid Pye, Jörge E. Cortes, Patricia Ault +5

   MaqolaOAOchiq kirish20082 iqtibos

   ABIABI:AkademIndex/2026.other.108153

3. Successful Completion of Pregnancy in a Patient With Chronic Myeloid Leukemia Without Active Intervention: A Case Report and Review of the Literature

   Suzanne Cole, Hagop M. Kantarjian, Patricia Ault +1

   Sharh maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.108155

4. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

   Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian +9

   MaqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.108166

5. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

   Andreas Hochhaus, Michele Baccarani, Richard T. Silver +31

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.108182

6. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

   Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat +13

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.312643